August 11, 2026
AI-Driven Radiology: Aidoc’s ‘First Read’ Receives FDA Breakthrough Designation to Combat Imaging Backlogs ai-driven-radiology-aidocs-first-read-receives-fda-breakthrough-designation-to-combat-imaging-backlogs

AI-Driven Radiology: Aidoc’s ‘First Read’ Receives FDA Breakthrough Designation to Combat Imaging Backlogs

Nana June 26, 2026
In a significant move to alleviate the mounting pressure on global healthcare systems, the US Food and...
Read More Read more about AI-Driven Radiology: Aidoc’s ‘First Read’ Receives FDA Breakthrough Designation to Combat Imaging Backlogs
Glaukos Achieves Key Milestone: Patient Enrollment Complete for Innovative Demodex Blepharitis Therapy glaukos-achieves-key-milestone-patient-enrollment-complete-for-innovative-demodex-blepharitis-therapy

Glaukos Achieves Key Milestone: Patient Enrollment Complete for Innovative Demodex Blepharitis Therapy

Iffa Jayyana June 26, 2026
SAN CLEMENTE, CA – June 26, 2026 – Glaukos Corporation, a leading ophthalmic technology company, has announced...
Read More Read more about Glaukos Achieves Key Milestone: Patient Enrollment Complete for Innovative Demodex Blepharitis Therapy
Revolutionizing Breast Cancer Screening: AI as a Collaborative Partner, Not a Replacement for Radiologists revolutionizing-breast-cancer-screening-ai-as-a-collaborative-partner-not-a-replacement-for-radiologists

Revolutionizing Breast Cancer Screening: AI as a Collaborative Partner, Not a Replacement for Radiologists

Suro Senen June 26, 2026
URBANA-CHAMPAIGN, IL – In a landmark study poised to redefine the future of medical diagnostics, new research...
Read More Read more about Revolutionizing Breast Cancer Screening: AI as a Collaborative Partner, Not a Replacement for Radiologists
A Paradigm Shift in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer a-paradigm-shift-in-oncology-fda-approves-sacituzumab-govitecan-for-metastatic-triple-negative-breast-cancer

A Paradigm Shift in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

Nana Muazin June 26, 2026
The landscape of breast cancer treatment has been fundamentally altered by the recent decision from the U.S....
Read More Read more about A Paradigm Shift in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer
Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes removing-ovaries-and-fallopian-tubes-linked-to-lower-risk-of-early-death-among-breast-cancer-patients-with-brca-cancer-genes

Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

Suro Senen June 26, 2026
Cambridge, UK – In a landmark study published in The Lancet Oncology, researchers from the University of...
Read More Read more about Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

You may have missed

insurance-shock-aca-marketplace-premiums-face-second-year-of-double-digit-hikes-for-2027

Insurance Shock: ACA Marketplace Premiums Face Second Year of Double-Digit Hikes for 2027

Reynand Wu August 11, 2026
ai-and-human-radiologists-a-collaborative-future-for-breast-cancer-screening

AI and Human Radiologists: A Collaborative Future for Breast Cancer Screening

Ali Ikhwan August 11, 2026
the-invisible-feature-how-eye-tracking-technology-is-redefining-facial-aesthetics-and-rhinoplasty

The Invisible Feature: How Eye-Tracking Technology is Redefining Facial Aesthetics and Rhinoplasty

Asro August 11, 2026
resmed-faces-fiscal-headwinds-ventilator-recall-and-macroeconomic-pressures-temper-growth-outlook

ResMed Faces Fiscal Headwinds: Ventilator Recall and Macroeconomic Pressures Temper Growth Outlook

Pevita Pearce August 11, 2026